<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">24416446</PMID>
        <DateCompleted>
            <Year>2014</Year>
            <Month>09</Month>
            <Day>08</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS One</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Simvastatin inhibits glucose metabolism and legumain activity in human myotubes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e85721</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0085721</ELocationID>
            <Abstract>
                <AbstractText>Simvastatin, a HMG-CoA reductase inhibitor, is prescribed worldwide to patients with hypercholesterolemia. Although simvastatin is well tolerated, side effects like myotoxicity are reported. The mechanism for statin-induced myotoxicity is still poorly understood. Reports have suggested impaired mitochondrial dysfunction as a contributor to the observed myotoxicity. In this regard, we wanted to study the effects of simvastatin on glucose metabolism and the activity of legumain, a cysteine protease. Legumain, being the only known asparaginyl endopeptidase, has caspase-like properties and is described to be involved in apoptosis. Recent evidences indicate a regulatory role of both glucose and statins on cysteine proteases in monocytes. Satellite cells were isolated from the Musculus obliquus internus abdominis of healthy human donors, proliferated and differentiated into polynuclear myotubes. Simvastatin with or without mevalonolactone, farnesyl pyrophosphate or geranylgeranyl pyrophosphate were introduced on day 5 of differentiation. After 48 h, cells were either harvested for immunoblotting, ELISA, cell viability assay, confocal imaging or enzyme activity analysis, or placed in a fuel handling system with [¹⁴C]glucose or [³H]deoxyglucose for uptake and oxidation studies. A dose-dependent decrease in both glucose uptake and oxidation were observed in mature myotubes after exposure to simvastatin in concentrations not influencing cell viability. In addition, simvastatin caused a decrease in maturation and activity of legumain. Dysregulation of glucose metabolism and decreased legumain activity by simvastatin points out new knowledge about the effects of statins on skeletal muscle, and may contribute to the understanding of the myotoxicity observed by statins.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Biosciences, School of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Solberg</LastName>
                    <ForeName>Rigmor</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Biosciences, School of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jacobsen</LastName>
                    <ForeName>Linn Løkken</ForeName>
                    <Initials>LL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Biosciences, School of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Voreland</LastName>
                    <ForeName>Anette Larsen</ForeName>
                    <Initials>AL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Biosciences, School of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rustan</LastName>
                    <ForeName>Arild Christian</ForeName>
                    <Initials>AC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Biosciences, School of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thoresen</LastName>
                    <ForeName>G Hege</ForeName>
                    <Initials>GH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Biosciences, School of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ; Department of Pharmacology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johansen</LastName>
                    <ForeName>Harald Thidemann</ForeName>
                    <Initials>HT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>01</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011106">Polyisoprenyl Phosphates</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012717">Sesquiterpenes</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>661X270Z3L</RegistryNumber>
                <NameOfSubstance UI="C015367">mevalonolactone</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>79W6B01D07</RegistryNumber>
                <NameOfSubstance UI="C004808">farnesyl pyrophosphate</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>AGG2FN16EV</RegistryNumber>
                <NameOfSubstance UI="D019821">Simvastatin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.4.22.-</RegistryNumber>
                <NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.4.22.1</RegistryNumber>
                <NameOfSubstance UI="D002401">Cathepsin B</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.4.22.15</RegistryNumber>
                <NameOfSubstance UI="D056668">Cathepsin L</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.4.22.34</RegistryNumber>
                <NameOfSubstance UI="C069586">asparaginylendopeptidase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>IY9XDZ35W2</RegistryNumber>
                <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>N21T0D88LX</RegistryNumber>
                <NameOfSubstance UI="C002963">geranylgeranyl pyrophosphate</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>S5UOB36OCZ</RegistryNumber>
                <NameOfSubstance UI="D008798">Mevalonic Acid</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="ErratumIn">
                <RefSource>PLoS One. 2014;9(3):e93202</RefSource>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D002401" MajorTopicYN="N">Cathepsin B</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056668" MajorTopicYN="N">Cathepsin L</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008798" MajorTopicYN="N">Mevalonic Acid</DescriptorName>
                <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018485" MajorTopicYN="N">Muscle Fibers, Skeletal</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010085" MajorTopicYN="N">Oxidative Phosphorylation</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011106" MajorTopicYN="N">Polyisoprenyl Phosphates</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012717" MajorTopicYN="N">Sesquiterpenes</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019821" MajorTopicYN="N">Simvastatin</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>08</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>9</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">24416446</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0085721</ArticleId>
            <ArticleId IdType="pii">PONE-D-13-35528</ArticleId>
            <ArticleId IdType="pmc">PMC3885717</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Biochem. 2001 Mar;268(5):1392-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11231291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2006 Feb 17;281(7):3757-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16249177</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cardiovasc Pharmacol. 2002 Aug;40(2):163-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12131545</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 2003 Jan 16;534(1-3):164-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12527380</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2003 Apr 2;289(13):1681-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12672737</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2003 Jun 1;63(11):2957-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12782603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2003 Aug 29;278(35):33194-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12775715</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2003 Oct 3;278(40):38980-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12860980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2004 Aug 28-Sep 3;364(9436):771-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15337403</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anal Biochem. 1976 May 7;72:248-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">942051</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Enzymol. 1981;80 Pt C:535-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7043200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1837-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16741146</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cardiovasc Pharmacol Ther. 2006 Jun;11(2):105-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16891287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Lipid Res. 2007 Apr;48(4):961-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17213484</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FASEB J. 2007 Dec;21(14):4087-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17634390</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Surg. 2008 Mar;95(3):333-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17968978</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Care. 2008 Apr;31(4):776-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18184901</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell. 2008 Mar 28;29(6):665-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18374643</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Pharm Sci. 2008 Apr 23;33(4-5):317-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18294823</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Sci. 2008 May;107(1):80-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18469500</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Sci. 2009 Jan;109(1):94-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19129682</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta. 2009 Feb;1788(2):470-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19109925</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Mol Cell Biol. 2009 Aug;10(8):513-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19603039</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2010 Jan 15;285(3):1790-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19915007</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Pharmacol. 2010 Mar;50(3):311-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19808950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 2010 Mar 23;55(12):1209-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20298928</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Lipid Res. 2010 Aug;51(8):2314-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20388919</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2010 Nov 5;402(1):70-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20920472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Exp Ther. 2011 Jul;338(1):62-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21467191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Free Radic Biol Med. 2012 Jan 1;52(1):198-207</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22080086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neoplasia. 2012 Apr;14(4):311-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22577346</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Atherosclerosis. 2012 Jul;223(1):144-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22658253</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochimie. 2012 Dec;94(12):2590-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22902879</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Cardiol. 2013 Jan 8;61(1):44-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23287371</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013;8(1):e52980</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23326369</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Tissue Res. 2013 Dec;354(3):671-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23749200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>APMIS. 2001 Nov;109(11):735-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11900052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomed Biochim Acta. 1986;45(11-12):1413-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3555467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomed Biochim Acta. 1991;50(4-6):531-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1801719</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Pharmacol. 1993 Mar;33(3):226-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8463436</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1994 Nov 19;344(8934):1383-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7968073</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biol Chem Hoppe Seyler. 1995 Mar;376(3):157-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7612192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1997 Mar 21;272(12):8090-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9065484</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol Appl Pharmacol. 1997 Jul;145(1):99-110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9221829</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Cell Dev Biol. 1997;13:779-808</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9442887</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1998 Aug 28;273(35):22298-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9712847</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 1998 Oct 30;438(1-2):114-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9821970</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6775-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10359788</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anal Biochem. 1999 Sep 10;273(2):278-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10469498</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2005 Apr 15;329(3):1067-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15752763</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2005 Mar 18;280(11):9855-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15764607</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
